Health and Science

Politics

Coronavirus

Biotech and Pharmaceuticals

Pharmaceuticals

Biotechnology

The U.S. government has awarded Novavax $1.6 billion to support the late-stage development and scale up in manufacturing of its Covid-19 vaccine. CNBC's Meg Tirrell reports.